ARTICLE | Company News
Teva creates Global Specialty Medicines group
April 25, 2013 12:01 AM UTC
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) named Rob Koremans as president and CEO of the newly formed Global Specialty Medicines group. Koremans joined Teva last year as president and CEO of Tev...